Gooding, Patricia
Harris, Kamelia
Peters, Sarah
Haddock, Gillian
Funding for this research was provided by:
Efficacy and Mechanism Evaluation Programme (13/161/25)
Efficacy and Mechanism Evaluation Programme (13/161/25)
Efficacy and Mechanism Evaluation Programme (13/161/25)
Efficacy and Mechanism Evaluation Programme (13/161/25)
Article History
Received: 2 March 2025
Accepted: 20 October 2025
First Online: 19 November 2025
Declarations
:
: Ethical approval for CARMS was gained from North West – Greater Manchester South Research Ethics Committee (REC reference: 17/NW/0089; IRAS project ID: 201644). Ethical approval for the Resilience, Psychosis and Suicidality (RePS) study was obtained from the North West-Greater Manchester Central Research Ethics Committee (REC reference: 17/NW/0211). Relevant ethical and legal guidelines concerning confidentiality and the storage of personal data were followed (e.g., General Data Protection Regulation). Signed informed consent forms were stored on NHS and/or University secure servers separate to the research data. This study was in compliance with, and adhered to the Declaration of Helsinki.
: Participants provided signed informed consent for quotes to be used for publications. All co-authors have read the manuscript and provided consent for this manuscript to be published.
: The CARMS project was funded by the Efficacy and Mechanism Evaluation (EME) Programme, an MRC and NIHR partnership (Reference number: 13/161/25). The views expressed in this publication are those of the author(s) and not necessarily those of the MRC, NIHR or the Department of Health and Social Care. The trial was hosted by Greater Manchester Mental Health NHS Foundation Trust, UK. The Sponsor is Manchester University, UK.
: This work was supported by the NIHR Manchester Biomedical Research Centre (NIHR203308). PG has acted as a non-paid suicide consultant for Self Help & The Big Life Group and Anxiety UK.